SEC EDGAR — 8-K filingsUnited States2 October 2026
8-K - CNS Pharmaceuticals, Inc. (0001729427) (Filer)
This is an official announcement record
Firsthand records what SEC EDGAR — 8-K filings announced and links to the original. The wording below is theirs, not ours.
Filed: 2026-10-02 AccNo: 0001683168-26-007552 Size: 320 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Read the official announcement
Opens www.sec.gov
More from SEC EDGAR — 8-K filings
- 8-K - Deep Isolation Nuclear, Inc. (0001918080) (Filer)2 October 2026
- 8-K - Fortress Net Lease REIT (0001966394) (Filer)2 October 2026
- 8-K - BUTLER NATIONAL CORP (0000015847) (Filer)2 October 2026
- 8-K - GENERAL MILLS INC (0000040704) (Filer)2 October 2026
- 8-K - Audax Private Credit Fund, LLC (0002033362) (Filer)2 October 2026
This content is for informational purposes only and is not financial, investment, tax, or legal advice. Rates, fees, and terms change and may differ from what is shown here; verify current details with the provider before acting. Consider consulting a qualified financial professional about your specific situation.